The efficacy and safety of Ganduqing granule for treating common cold with qi deficiency leading to lingering of evil syndrome: a randomized, double-blind, placebo, parallel-group, multicenter- controlled trial

Hospital of of Chengdu University of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•(1) Meet the diagnosis of common cold according to Western medicine;
•(2) Meet the diagnosis of common cold with qi deficiency syndrome according to Traditional Chinese Medicine;
•(3) Repeated colds every year, more than 4 times;
•(4) Symptom presenting within 48 hours;
•(5) Aged between 18 and 70 years;
•(6) Voluntarily participate and provide signed informed consent.

•(1) Influenza;
•(2) Patient's body temperature over 39 degree C;
•(3) White blood cell count > 12.0 x 10^9/L and/or neutrophil percentage > 80%;
•(4) Patients with other infectious diseases of the respiratory tract, such as acute herpetic pharyngitis, acute viral pharyngitis, acute herpetic laryngitis, acute viral laryngitis, acute tonsillitis, and pneumonia;
•(5) Liver function levels (alanine aminotransferase (ALT) and aspartate aminotransferase (AST)) 1.5 times higher than the upper limit of normal or abnormal serum creatinine;
•(6) Allergic or possibility of being allergic to the ingredients in the study drug;
•(7) Patients with severe cardio-cerebrovascular, lung, kidney or hematopoietic system diseases;
•(8) Patients who have participated in other drug clinical trials within one month or are participating in other drug clinical trials;
•(9) Other medicines (including cold, antibiotics, antivirals and similar traditional Chinese medicines) that have been used to treat the disease since symptom presenting within 48 hours;
•(10) Pregnant and lactating women;
•(11) Psychiatric patients;
•(12) Identified by the investigator as inappropriate to participate in this study.

发起方

Hospital of of Chengdu University of Traditional Chinese Medicine